General Information


DRAVP ID  DRAVPe00073

Peptide Name   4322(derived from the RNase H domain of HIV-1 RT (20-mes))

Sequence  IKKEKVYLAWVPAHKGIGN

Sequence Length  19

UniProt ID  No entry found

Source  Synthetic construct(derived from HIV-1 Reverse Transcriptase)



Activity Information


Target Organism  HIV

Assay  Dot-blot assay

Activity 

  • [Ref.15790559]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>120 µM);inhibition of strand transfer catalyzed by integrase(IC50>120 µM);inhibition of disintegration catalyzed by integrase(IC50>120 µM).

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity 

  • No cytotoxicity information or data found in the reference(s) presented in this entry

Binding Target  Integrase

Mechanism  Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3′-end processing and strand transfer) and inhibit virus replication.



Structure Information


PDB ID  None

Predicted Structure Download  DRAVPe00073

Linear/Cyclic  Linear

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Stereochemistry  L



Physicochemical Information


Formula  C102H163N27O24

Absent amino acids  CDFMQRST

Common amino acids  K

Mass  2151.58

Pl  9.83

Basic residues  5

Acidic residues  1

Hydrophobic residues  8

Net charge  4

Boman Index  -978

Hydrophobicity  -29.47

Aliphatic Index  102.63

Half Life 

  •     Mammalian:20 hour
  •     Yeast:30 min
  •     E.coli:>10 hour

Extinction Coefficient cystines  6990

Absorbance 280nm  388.33

Polar residues  4



Literature Information


Literature 1

Title   Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.

Pubmed ID   15790559

Reference   J Biol Chem. 2005 Jun 10;280(23):21987-96.

Author   Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.

DOI   10.1074/jbc.M414679200